Featured Research

from universities, journals, and other organizations

Tiny Backpacks For Cells: Polymer Patches Could Ferry Drugs, Assist In Cancer Diagnosis

Date:
November 7, 2008
Source:
Massachusetts Institute of Technology
Summary:
MIT engineers have outfitted cells with tiny "backpacks" that could allow them to deliver chemotherapy agents, diagnose tumors or become building blocks for tissue engineering.

MIT researchers have developed a technique to attach tiny polymer "backpacks" to cells. This immune system cells, a B lymphocyte sports one. The scale bar is 10 micrometers.
Credit: Image courtesy of American Chemical Society

MIT engineers have outfitted cells with tiny "backpacks" that could allow them to deliver chemotherapy agents, diagnose tumors or become building blocks for tissue engineering.

Michael Rubner, director of MIT's Center for Materials Science and Engineering and senior author of a paper on the work that appeared online in Nano Letters on Nov. 5, said he believes this is the first time anyone has attached such a synthetic patch to a cell.

The polymer backpacks allow researchers to use cells to ferry tiny cargoes and manipulate their movements using magnetic fields. Since each patch covers only a small portion of the cell surface, it does not interfere with the cell's normal functions or prevent it from interacting with the external environment.

"The goal is to perturb the cell as little as possible," said Robert Cohen, the St. Laurent Professor of Chemical Engineering at MIT and an author of the paper.

The researchers worked with B and T cells, two types of immune cells that can home to various tissues in the body, including tumors, infection sites, and lymphoid tissues — a trait that could be exploited to achieve targeted drug or vaccine delivery.

"The idea is that we use cells as vectors to carry materials to tumors, infection sites or other tissue sites," said Darrell Irvine, an author of the paper and associate professor of materials science and engineering and biological engineering.

Cellular backpacks carrying chemotherapy agents could target tumor cells, while cells equipped with patches carrying imaging agents could help identify tumors by binding to protein markers expressed by cancer cells.

Another possible application is in tissue engineering. Patches could be designed that allow researchers to align cells in a certain pattern, eliminating the need for a tissue scaffold.

The polymer patch system consists of three layers, each with a different function, stacked onto a surface. The bottom layer tethers the polymer to the surface, the middle layer contains the payload, and the top layer serves as a "hook" that catches and binds cells.

Once the layers are set up, cells enter the system and flow across the surface, getting stuck on the polymer hooks. The patch is then detached from the surface by simply lowering the temperature, and the cells float away, with backpacks attached.

"The rest of the cell is untouched and able to interact with the environment," said Albert Swiston, lead author of the paper and a graduate student in materials science and engineering.

The researchers found that T cells with backpacks were able to perform their normal functions, including migrating across a surface, just as they would without anything attached.

By loading the backpacks with magnetic nanoparticles, the researchers can control the cells' movement with a magnetic field.

Because the polymer synthesis and assembly takes place before the patches are attached to cells, there is plenty of opportunity to tweak the process to improve the polymers' effectiveness and ensure they won't be toxic to cells, the researchers say.

Other authors of the paper are Soong Ho Um, a postdoctoral associate in the Departments of Materials Science and Engineering and Biological Engineering, and Connie Cheng, a recent Harvard graduate.

The research was funded by the National Science Foundation Materials Research Science and Engineering Center and an NSF Graduate Research Fellowship.


Story Source:

The above story is based on materials provided by Massachusetts Institute of Technology. Note: Materials may be edited for content and length.


Cite This Page:

Massachusetts Institute of Technology. "Tiny Backpacks For Cells: Polymer Patches Could Ferry Drugs, Assist In Cancer Diagnosis." ScienceDaily. ScienceDaily, 7 November 2008. <www.sciencedaily.com/releases/2008/11/081106122417.htm>.
Massachusetts Institute of Technology. (2008, November 7). Tiny Backpacks For Cells: Polymer Patches Could Ferry Drugs, Assist In Cancer Diagnosis. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2008/11/081106122417.htm
Massachusetts Institute of Technology. "Tiny Backpacks For Cells: Polymer Patches Could Ferry Drugs, Assist In Cancer Diagnosis." ScienceDaily. www.sciencedaily.com/releases/2008/11/081106122417.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins